High Stable
Peptidomimetic development
Based on high-throughput peptidomimetic rapid development technology, PepDomTM helps customers achieve the best results in a shorter time.
Learn MoreAdvanced technology facilitates the rapid development of peptidomimetics for various targets and special effects.
Establish a high-capacity peptidomimetic library, and conduct drug screening for diseases in various fields to obtain the best therapeutic effect.
Featured peptidomimetic biotinylation and other modification services help your target drug show better in vivo half-life.
Utilize our technology platform to develop more effective peptidomimetic reagents for detection and diagnosis.
PepDomTM is a professional technology platform that will use it's unique technology to assist in the rapid development and screening of customer's target peptidomimetics.
Learn MoreCD BioSciences has grown into one of the world's largest independent biotechnology companies, connecting millions of researchers and partners around the world. Based on our high-throughput peptidomimetic development platform (PepDomTM), we are committed to providing universities, research institutes, biotechnology companies and pharmaceutical companies with a wide range of high-stability peptidomimetic products and comprehensive services to advance basic science and drug development.
Learn MoreThe development of peptidomimetic will bring more possibilities to the world.
The binding function of peptidomimetic will facilitate the treatment of more disease areas.
Good protease resistance helps peptidomimetics to be more widely used in the food field.
For animal research, peptidomimetics will enable more economical diagnostic and therapeutic development.
The addition of peptidomimetics allows biomaterials to have broader functionality and stability, helping the advancement of biotechnology.
Diversified peptidomimetic development to fully meet the diverse functional needs of cosmetics.